TY - CHAP PY - 2010 DA - 2010// BT - Cancer Facts and Figures ID - ref1 ER - TY - STD TI - Paclitaxel plus carboplatin versus standard chemotherapy with either single-agent carboplatin or cyclophosphamide, doxorubicin, and cisplatin in women with ovarian cancer: the ICON3 randomised trial. Lancet. 2002, 360: 505-515. ID - ref2 ER - TY - JOUR AU - Bratasz, A. AU - Weir, N. M. AU - Parinandi, N. L. AU - Zweier, J. L. AU - Sridhar, R. AU - Ignarro, L. J. AU - Kuppusamy, P. PY - 2006 DA - 2006// TI - Reversal to cisplatin sensitivity in recurrent human ovarian cancer cells by NCX-4016, a nitro derivative of aspirin JO - Proc Natl Acad Sci USA VL - 103 UR - https://doi.org/10.1073/pnas.0511250103 DO - 10.1073/pnas.0511250103 ID - Bratasz2006 ER - TY - JOUR AU - McGuire, W. P. AU - Hoskins, W. J. AU - Brady, M. F. AU - Kucera, P. R. AU - Partridge, E. E. AU - Look, K. Y. AU - Clarke-Pearson, D. L. AU - Davidson, M. PY - 1996 DA - 1996// TI - Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer JO - N Engl J Med VL - 334 UR - https://doi.org/10.1056/NEJM199601043340101 DO - 10.1056/NEJM199601043340101 ID - McGuire1996 ER - TY - JOUR AU - Medici, V. AU - Sturniolo, G. C. PY - 2008 DA - 2008// TI - Tetrathiomolybdate, a copper chelator for the treatment of Wilson disease, pulmonary fibrosis and other indications JO - IDrugs VL - 11 ID - Medici2008 ER - TY - JOUR AU - Juarez, J. C. AU - Betancourt, O. AU - Pirie-Shepherd, S. R. AU - Guan, X. AU - Price, M. L. AU - Shaw, D. E. AU - Mazar, A. P. AU - Donate, F. PY - 2006 DA - 2006// TI - Copper binding by tetrathiomolybdate attenuates angiogenesis and tumor cell proliferation through the inhibition of superoxide dismutase 1 JO - Clin Cancer Res VL - 12 UR - https://doi.org/10.1158/1078-0432.CCR-06-0171 DO - 10.1158/1078-0432.CCR-06-0171 ID - Juarez2006 ER - TY - JOUR AU - Kim, K. K. AU - Kawar, N. M. AU - Singh, R. K. AU - Lange, T. S. AU - Brard, L. AU - Moore, R. G. PY - 2011 DA - 2011// TI - Tetrathiomolybdate induces doxorubicin sensitivity in resistant tumor cell lines JO - Gynecol Oncol VL - 122 UR - https://doi.org/10.1016/j.ygyno.2011.03.035 DO - 10.1016/j.ygyno.2011.03.035 ID - Kim2011 ER - TY - JOUR AU - Koto, K. S. AU - Lescault, P. AU - Brard, L. AU - Kim, K. AU - Singh, R. K. AU - Bond, J. AU - Illenye, S. AU - Slavik, M. A. AU - Ashikaga, T. AU - Saulnier Sholler, G. L. PY - 2011 DA - 2011// TI - Antitumor activity of nifurtimox is enhanced with tetrathiomolybdate in medulloblastoma JO - Int J Oncol VL - 38 ID - Koto2011 ER - TY - JOUR AU - Ishida, S. AU - McCormick, F. AU - Smith-McCune, K. AU - Hanahan, D. PY - 2010 DA - 2010// TI - Enhancing tumor-specific uptake of the anticancer drug cisplatin with a copper chelator JO - Cancer Cell VL - 17 UR - https://doi.org/10.1016/j.ccr.2010.04.011 DO - 10.1016/j.ccr.2010.04.011 ID - Ishida2010 ER - TY - JOUR AU - Kumar, P. AU - Yadav, A. AU - Patel, S. N. AU - Islam, M. AU - Pan, Q. AU - Merajver, S. D. AU - Teknos, T. N. PY - 2010 DA - 2010// TI - Tetrathiomolybdate inhibits head and neck cancer metastasis by decreasing tumor cell motility, invasiveness and by promoting tumor cell anoikis JO - Mol Cancer VL - 9 UR - https://doi.org/10.1186/1476-4598-9-206 DO - 10.1186/1476-4598-9-206 ID - Kumar2010 ER - TY - JOUR AU - Brewer, G. J. AU - Dick, R. D. AU - Grover, D. K. AU - LeClaire, V. AU - Tseng, M. AU - Wicha, M. AU - Pienta, K. AU - Redman, B. G. AU - Jahan, T. AU - Sondak, V. K. PY - 2000 DA - 2000// TI - Treatment of metastatic cancer with tetrathiomolybdate, an anticopper, antiangiogenic agent: Phase I study JO - Clin Cancer Res VL - 6 ID - Brewer2000 ER - TY - JOUR AU - Pass, H. I. AU - Brewer, G. J. AU - Dick, R. AU - Carbone, M. AU - Merajver, S. PY - 2008 DA - 2008// TI - A phase II trial of tetrathiomolybdate after surgery for malignant mesothelioma: final results JO - Ann Thorac Surg VL - 86 UR - https://doi.org/10.1016/j.athoracsur.2008.03.016 DO - 10.1016/j.athoracsur.2008.03.016 ID - Pass2008 ER - TY - JOUR AU - Redman, B. G. AU - Esper, P. AU - Pan, Q. AU - Dunn, R. L. AU - Hussain, H. K. AU - Chenevert, T. AU - Brewer, G. J. AU - Merajver, S. D. PY - 2003 DA - 2003// TI - Phase II trial of tetrathiomolybdate in patients with advanced kidney cancer JO - Clin Cancer Res VL - 9 ID - Redman2003 ER - TY - JOUR AU - Creech, R. H. AU - Shah, M. K. AU - Catalano, R. B. AU - Dierks, K. AU - Dayal, H. AU - Goldberg-Alberts, R. PY - 1985 DA - 1985// TI - Phase II study of low-dose mitomycin in patients with ovarian cancer previously treated with chemotherapy JO - Cancer Treat Rep VL - 69 ID - Creech1985 ER - TY - JOUR AU - Rosa, D. D. AU - Awada, A. AU - Mano, M. S. AU - Selleslags, J. AU - Lebrun, F. AU - Gil, T. AU - Piccart, M. J. AU - D'Hondt, V. PY - 2008 DA - 2008// TI - Oxaliplatin/5fluorouracil-based chemotherapy was active and well tolerated in heavily pretreated patients with ovarian carcinoma JO - Arch Gynecol Obstet VL - 278 UR - https://doi.org/10.1007/s00404-008-0592-9 DO - 10.1007/s00404-008-0592-9 ID - Rosa2008 ER - TY - JOUR AU - Weiss, R. B. PY - 1992 DA - 1992// TI - The anthracyclines: will we ever find a better doxorubicin? JO - Semin Oncol VL - 19 ID - Weiss1992 ER - TY - JOUR AU - Garcia, A. A. AU - Morgan, R. AU - McNamara, M. AU - Scudder, S. AU - Tsao-Wei, D. AU - Groshen, S. AU - Frgala, T. AU - Kim, Y. AU - Reynolds, C. P. PY - 2004 DA - 2004// TI - Phase II trial of fenretinide (4-HPR) in recurrent ovarian and primary peritoneal carcinoma: A California Cancer Consortium trial JO - Journal of Clinical Oncology, 2004 ASCO Annual Meeting Proceedings (Post-Meeting Edition) VL - 22 ID - Garcia2004 ER - TY - JOUR AU - Appierto, V. AU - Tiberio, P. AU - Villani, M. G. AU - Cavadini, E. AU - Formelli, F. PY - 2009 DA - 2009// TI - PLAB induction in fenretinide-induced apoptosis of ovarian cancer cells occurs via a ROS-dependent mechanism involving ER stress and JNK activation JO - Carcinogenesis VL - 30 UR - https://doi.org/10.1093/carcin/bgp067 DO - 10.1093/carcin/bgp067 ID - Appierto2009 ER - TY - JOUR AU - Koedrith, P. AU - Seo, Y. R. PY - 2011 DA - 2011// TI - Enhancement of the efficacy of mitomycin c-mediated apoptosis in human colon cancer cells with RNAi-based thioredoxin reductase 1 deficiency JO - Experimental and Therapeutic Medicine VL - 2 ID - Koedrith2011 ER - TY - JOUR AU - Hwang, P. M. AU - Bunz, F. AU - Yu, J. AU - Rago, C. AU - Chan, T. A. AU - Murphy, M. P. AU - Kelso, G. F. AU - Smith, R. A. AU - Kinzler, K. W. AU - Vogelstein, B. PY - 2001 DA - 2001// TI - Ferredoxin reductase affects p53-dependent, 5-fluorouracil-induced apoptosis in colorectal cancer cells JO - Nat Med VL - 7 UR - https://doi.org/10.1038/nm1001-1111 DO - 10.1038/nm1001-1111 ID - Hwang2001 ER - TY - JOUR AU - Sinha, B. K. AU - Mimnaugh, E. G. AU - Rajagopalan, S. AU - Myers, C. E. PY - 1989 DA - 1989// TI - Adriamycin activation and oxygen free radical formation in human breast tumor cells: protective role of glutathione peroxidase in adriamycin resistance JO - Cancer Res VL - 49 ID - Sinha1989 ER - TY - JOUR AU - Vichai, V. AU - Kirtikara, K. PY - 2006 DA - 2006// TI - Sulforhodamine B colorimetric assay for cytotoxicity screening JO - Nat Protoc VL - 1 UR - https://doi.org/10.1038/nprot.2006.179 DO - 10.1038/nprot.2006.179 ID - Vichai2006 ER - TY - JOUR AU - Kim, K. K. AU - Singh, R. K. AU - Strongin, R. M. AU - Moore, R. G. AU - Brard, L. AU - Lange, T. S. PY - 2011 DA - 2011// TI - Organometallic Iron(III)-Salophene Exerts Cytotoxic Properties in Neuroblastoma Cells via MAPK Activation and ROS Generation JO - PLoS One VL - 6 UR - https://doi.org/10.1371/journal.pone.0019049 DO - 10.1371/journal.pone.0019049 ID - Kim2011 ER - TY - JOUR AU - Kim, R. AU - Emi, M. AU - Tanabe, K. AU - Murakami, S. AU - Uchida, Y. AU - Arihiro, K. PY - 2006 DA - 2006// TI - Regulation and interplay of apoptotic and non-apoptotic cell death JO - J Pathol VL - 208 UR - https://doi.org/10.1002/path.1885 DO - 10.1002/path.1885 ID - Kim2006 ER - TY - JOUR AU - Petit, P. X. AU - Lecoeur, H. AU - Zorn, E. AU - Dauguet, C. AU - Mignotte, B. AU - Gougeon, M. L. PY - 1995 DA - 1995// TI - Alterations in mitochondrial structure and function are early events of dexamethasone-induced thymocyte apoptosis JO - J Cell Biol VL - 130 UR - https://doi.org/10.1083/jcb.130.1.157 DO - 10.1083/jcb.130.1.157 ID - Petit1995 ER - TY - JOUR AU - Gewirtz, D. A. PY - 1999 DA - 1999// TI - A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin JO - Biochem Pharmacol VL - 57 UR - https://doi.org/10.1016/S0006-2952(98)00307-4 DO - 10.1016/S0006-2952(98)00307-4 ID - Gewirtz1999 ER - TY - JOUR AU - Swift, L. P. AU - Rephaeli, A. AU - Nudelman, A. AU - Phillips, D. R. AU - Cutts, S. M. PY - 2006 DA - 2006// TI - Doxorubicin-DNA adducts induce a non-topoisomerase II-mediated form of cell death JO - Cancer Res VL - 66 UR - https://doi.org/10.1158/0008-5472.CAN-05-3410 DO - 10.1158/0008-5472.CAN-05-3410 ID - Swift2006 ER - TY - JOUR AU - Dusre, L. AU - Mimnaugh, E. G. AU - Myers, C. E. AU - Sinha, B. K. PY - 1989 DA - 1989// TI - Potentiation of doxorubicin cytotoxicity by buthionine sulfoximine in multidrug-resistant human breast tumor cells JO - Cancer Res VL - 49 ID - Dusre1989 ER - TY - JOUR AU - Gouaze, V. AU - Mirault, M. E. AU - Carpentier, S. AU - Salvayre, R. AU - Levade, T. AU - Andrieu-Abadie, N. PY - 2001 DA - 2001// TI - Glutathione peroxidase-1 overexpression prevents ceramide production and partially inhibits apoptosis in doxorubicin-treated human breast carcinoma cells JO - Mol Pharmacol VL - 60 ID - Gouaze2001 ER - TY - JOUR AU - Li, S. AU - Zhou, Y. AU - Wang, R. AU - Zhang, H. AU - Dong, Y. AU - Ip, C. PY - 2007 DA - 2007// TI - Selenium sensitizes MCF-7 breast cancer cells to doxorubicin-induced apoptosis through modulation of phospho-Akt and its downstream substrates JO - Mol Cancer Ther VL - 6 UR - https://doi.org/10.1158/1535-7163.MCT-06-0643 DO - 10.1158/1535-7163.MCT-06-0643 ID - Li2007 ER - TY - JOUR AU - Hou, G. AU - Dick, R. AU - Abrams, G. D. AU - Brewer, G. J. PY - 2005 DA - 2005// TI - Tetrathiomolybdate protects against cardiac damage by doxorubicin in mice JO - J Lab Clin Med VL - 146 UR - https://doi.org/10.1016/j.lab.2005.07.004 DO - 10.1016/j.lab.2005.07.004 ID - Hou2005 ER - TY - JOUR AU - Shiraha, Y. AU - Sakai, K. AU - Teranaka, T. PY - 1958 DA - 1958// TI - Clinical trials of mitomycin C, a new antitumor antibiotic; preliminary report of results obtained in 82 consecutive cases in the field of general surgery JO - Antibiot Annu VL - 6 ID - Shiraha1958 ER - TY - JOUR AU - Aoki, Y. AU - Kurata, H. AU - Watanabe, M. AU - Fujita, K. AU - Tanaka, K. PY - 2004 DA - 2004// TI - Combination chemotherapy with irinotecan hydrochloride (CPT-11) and mitomycin C in platinum-refractory ovarian cancer JO - Am J Clin Oncol VL - 27 UR - https://doi.org/10.1097/01.coc.0000128630.26754.fb DO - 10.1097/01.coc.0000128630.26754.fb ID - Aoki2004 ER - TY - JOUR AU - Brewer, G. J. AU - Johnson, V. AU - Dick, R. D. AU - Kluin, K. J. AU - Fink, J. K. AU - Brunberg, J. A. PY - 1996 DA - 1996// TI - Treatment of Wilson disease with ammonium tetrathiomolybdate. II. Initial therapy in 33 neurologically affected patients and follow-up with zinc therapy JO - Arch Neurol VL - 53 UR - https://doi.org/10.1001/archneur.1996.00550100103019 DO - 10.1001/archneur.1996.00550100103019 ID - Brewer1996 ER - TY - JOUR AU - Longley, D. B. AU - Harkin, D. P. AU - Johnston, P. G. PY - 2003 DA - 2003// TI - 5-fluorouracil: mechanisms of action and clinical strategies JO - Nat Rev Cancer VL - 3 UR - https://doi.org/10.1038/nrc1074 DO - 10.1038/nrc1074 ID - Longley2003 ER - TY - JOUR AU - Prefontaine, M. AU - Donovan, J. T. AU - Powell, J. L. AU - Buley, L. PY - 1996 DA - 1996// TI - Treatment of refractory ovarian cancer with 5-fluorouracil and leucovorin JO - Gynecol Oncol VL - 61 UR - https://doi.org/10.1006/gyno.1996.0134 DO - 10.1006/gyno.1996.0134 ID - Prefontaine1996 ER - TY - JOUR AU - Wu, J. M. AU - DiPietrantonio, A. M. AU - Hsieh, T. C. PY - 2001 DA - 2001// TI - Mechanism of fenretinide (4-HPR)-induced cell death JO - Apoptosis VL - 6 UR - https://doi.org/10.1023/A:1011342220621 DO - 10.1023/A:1011342220621 ID - Wu2001 ER - TY - JOUR AU - Gupte, A. AU - Mumper, R. J. PY - 2009 DA - 2009// TI - Elevated copper and oxidative stress in cancer cells as a target for cancer treatment JO - Cancer Treat Rev VL - 35 UR - https://doi.org/10.1016/j.ctrv.2008.07.004 DO - 10.1016/j.ctrv.2008.07.004 ID - Gupte2009 ER - TY - JOUR AU - Waris, G. AU - Ahsan, H. PY - 2006 DA - 2006// TI - Reactive oxygen species: role in the development of cancer and various chronic conditions JO - J Carcinog VL - 5 UR - https://doi.org/10.1186/1477-3163-5-14 DO - 10.1186/1477-3163-5-14 ID - Waris2006 ER - TY - JOUR AU - Hileman, E. O. AU - Liu, J. AU - Albitar, M. AU - Keating, M. J. AU - Huang, P. PY - 2004 DA - 2004// TI - Intrinsic oxidative stress in cancer cells: a biochemical basis for therapeutic selectivity JO - Cancer Chemother Pharmacol VL - 53 UR - https://doi.org/10.1007/s00280-003-0726-5 DO - 10.1007/s00280-003-0726-5 ID - Hileman2004 ER - TY - JOUR AU - Trachootham, D. AU - Alexandre, J. AU - Huang, P. PY - 2009 DA - 2009// TI - Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? JO - Nat Rev Drug Discov VL - 8 UR - https://doi.org/10.1038/nrd2803 DO - 10.1038/nrd2803 ID - Trachootham2009 ER - TY - JOUR AU - Kim, J. S. AU - Lee, J. H. AU - Jeong, W. W. AU - Choi, D. H. AU - Cha, H. J. AU - Kim, D. H. AU - Kwon, J. K. AU - Park, S. E. AU - Park, J. H. AU - Cho, H. R. PY - 2008 DA - 2008// TI - Reactive oxygen species-dependent EndoG release mediates cisplatin-induced caspase-independent apoptosis in human head and neck squamous carcinoma cells JO - Int J Cancer VL - 122 UR - https://doi.org/10.1002/ijc.23158 DO - 10.1002/ijc.23158 ID - Kim2008 ER - TY - JOUR AU - Mansat-de Mas, V. AU - Bezombes, C. AU - Quillet-Mary, A. AU - Bettaieb, A. AU - D'orgeix, A. D. AU - Laurent, G. AU - Jaffrezou, J. P. PY - 1999 DA - 1999// TI - Implication of radical oxygen species in ceramide generation, c-Jun N-terminal kinase activation and apoptosis induced by daunorubicin JO - Mol Pharmacol VL - 56 ID - Mansat-de Mas1999 ER - TY - JOUR AU - Tsai-Turton, M. AU - Luong, B. T. AU - Tan, Y. AU - Luderer, U. PY - 2007 DA - 2007// TI - Cyclophosphamide-induced apoptosis in COV434 human granulosa cells involves oxidative stress and glutathione depletion JO - Toxicol Sci VL - 98 UR - https://doi.org/10.1093/toxsci/kfm087 DO - 10.1093/toxsci/kfm087 ID - Tsai-Turton2007 ER - TY - JOUR AU - Brown, D. P. AU - Chin-Sinex, H. AU - Nie, B. AU - Mendonca, M. S. AU - Wang, M. PY - 2009 DA - 2009// TI - Targeting superoxide dismutase 1 to overcome cisplatin resistance in human ovarian cancer JO - Cancer Chemother Pharmacol VL - 63 UR - https://doi.org/10.1007/s00280-008-0791-x DO - 10.1007/s00280-008-0791-x ID - Brown2009 ER - TY - JOUR AU - Kang, Y. H. AU - Lee, S. J. PY - 2008 DA - 2008// TI - The role of p38 MAPK and JNK in Arsenic trioxide-induced mitochondrial cell death in human cervical cancer cells JO - J Cell Physiol VL - 217 UR - https://doi.org/10.1002/jcp.21470 DO - 10.1002/jcp.21470 ID - Kang2008 ER - TY - JOUR AU - Osone, S. AU - Hosoi, H. AU - Kuwahara, Y. AU - Matsumoto, Y. AU - Iehara, T. AU - Sugimoto, T. PY - 2004 DA - 2004// TI - Fenretinide induces sustained-activation of JNK/p38 MAPK and apoptosis in a reactive oxygen species-dependent manner in neuroblastoma cells JO - Int J Cancer VL - 112 UR - https://doi.org/10.1002/ijc.20412 DO - 10.1002/ijc.20412 ID - Osone2004 ER - TY - JOUR AU - Mansouri, A. AU - Ridgway, L. D. AU - Korapati, A. L. AU - Zhang, Q. AU - Tian, L. AU - Wang, Y. AU - Siddik, Z. H. AU - Mills, G. B. AU - Claret, F. X. PY - 2003 DA - 2003// TI - Sustained activation of JNK/p38 MAPK pathways in response to cisplatin leads to Fas ligand induction and cell death in ovarian carcinoma cells JO - J Biol Chem VL - 278 UR - https://doi.org/10.1074/jbc.M208134200 DO - 10.1074/jbc.M208134200 ID - Mansouri2003 ER - TY - STD TI - The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2407/12/147/prepub UR - http://www.biomedcentral.com/1471-2407/12/147/prepub ID - ref49 ER -